PPBT Purple Biotech Ltd.
$1.72▼ -1.15%
Healthcare
Other
After hours
$1.76▲ +2.33%
Sep 11, 7:37 PM ET
Volume 145.8K
Avg Volume (10D) 7.89M
Key Metrics & Fundamentals
Market Cap
$2.80M
P/E Ratio
0.0
Div Yield
–%
52W Range
1.16 - 14.10
% vs 50 MA
10.03%
% vs 200 MA
-57.92%
RSI-14
51.9
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.53
Free Cash Flow
-$2.51M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.15M
COGS
–
Operating Exp
$1.30M
Operating Income
-$1.30M
EBIT
-$1.30M
Pretax Income
$441,000
Net Income
$441,000
EPS (Diluted)
0.40
Price & Volume History
Loading chart…
Recent News
Top Midday Gainers
MT Newswires · Sep 2, 2026 5:50 PM
Purple Biotech U.S. Patent Allowance Strengthens CAPTN-3 Multispecific Antibody Protection
InvestorsHub · Sep 2, 2026 3:07 PM
New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies
GlobeNewswire · Sep 2, 2026 11:30 AM
Purple Biotech Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 7, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PPBT's money flow as a full page
Social Sentiment
No Reddit posts found for PPBT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.